EPCAM and breast cancer: Breast cancer stem cell (BCSC)-specific markers [87] were highly reduced upon VDAC1 silencing in tumours established from the TNBC MDA-MB-231cell line, including ALDH1, CD133, EPCAM, SOX2 and KLF4 (Figure 4, Figure S1B).